Drug Information

Drug General Information
Drug ID
D07UEJ
Former ID
DIB000423
Drug Name
Empagli ozin
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Investigative [533123]
Company
Boehringer ingelheim pharmaceuticals; eli lilly
Target and Pathway
Target(s) SLGT2 Target Info Modulator [533123]
Reactome Hexose transport
Na+-dependent glucose transporters
Inositol transporters
WikiPathways NRF2 pathway
Nuclear Receptors Meta-Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 5331232014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81.
Ref 5331232014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.